Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a caucasian patient with HIV

A 48 -year-old Caucasian male patient presented with severe adverse drug events (ADEs) while being treated with a standard dose (600mg/day) of efavirenz. The patient's clinical course was favourable; however, he also described intense nightmares, cramps in his legs and anxiety disturbances that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical drug investigation 2010-06, Vol.30 (5), p.405
Hauptverfasser: Figueroa, Salvador Cabrera, Gomez, Alicia Iglesias, Ma, de la Paz Valverde Merino, Maria, Hurle, Alfonso Dominguez-Gil, Sanchez, Miguel Cordero
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!